Potential of Farnesyl Transferase Inhibitors in Combination Regimens in Squamous Cell Carcinomas
Current therapies for recurrent and metastatic SCC are associated with poor outcomes, and options for later lines of treatment are limited. Insights into potential therapeutic targets, as well as mechanisms of resistance to available therapies, have begun to be elucidated, creating the basis for exp...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
MDPI AG
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/788d638e52cd42a7b9d103cf883e0e5b |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|